期刊文献+

住院患者下呼吸道肠球菌属感染及耐药分析 被引量:29

Antibiotic Resistance and Enterococcal Infections among Inpatients with Lower Respiratory Infection
下载PDF
导出
摘要 目的 调查我院住院患者下呼吸道肠球菌感染及其耐药。方法 回顾性分析 2 0 0 0年 10月~ 2 0 0 2年 11月分离出肠球菌属住院患者的临床资料和耐药情况。结果 我院痰标本共分离肠球菌属病、侵入性操作和长期持续使用抗生素可能是肠球菌感染的危险因素 ;药敏结果显示 ,氨苄西林和青霉素对粪肠球菌敏感性为 83.3%和 77.8% ,屎肠球菌耐药率高于粪肠球菌 ,二者对万古霉素的敏感性为 10 0 % ,高水平耐氨基糖苷类肠球菌(HL AR)分离率为 80 .2 %。结论 下呼吸道肠球菌感染的发生率增加 ,万古霉素抗菌活性最强 ,合理及时治疗是关键。 OBJECTIVE To investigate the prevalence of enterococcal infection and the susceptibility of Enterococcus to antibacterial agents in hospitalized patients of our hospital. METHODS Retrospective study of the clinical materials of 101 cases with lower respiratory tract infection caused by Enterococcus in hospital,bacterial susceptibility was analyzed. RESULTS A total of 101 Enterococcus strains were isolated from sputum,14 cases from respiratory ward and 19 cases from RICU. Ages, prolonged hospitalization,severe underlying diseases,invasive operation and application of multiple antibiotics might be the risk factors of Enterococcus infection. Ampicillin and penicillin were susceptible against E. faecalis ,inhibition rates being 83.3% and 77.8%,respectively. Strains of E.faecium were more resistant than that of E. faecalis . Vancomycin was the most active agent against enterococcal isolates. In 101 isolated strains 81 were high level aminoglycoside-resistant (HLAR). CONCLUSIONS The prevalence of enterococcal infection in lower respiratory tract is increased. Vancomycin has the best antibacterial activity against Enterococcus . Early diagnosis and rational treatment are the key to cure these patients.
出处 《中华医院感染学杂志》 CAS CSCD 2004年第5期585-587,共3页 Chinese Journal of Nosocomiology
关键词 肠球菌属 药物敏感性 抗菌药 Enterococcus Antibiotic susceptibility Antibacterial agents
  • 相关文献

参考文献5

二级参考文献49

  • 1汪复.抗菌药物临床应用进展[J].中华传染病杂志,1996,14(1):36-40. 被引量:22
  • 2汪复,张敬德,朱德妹,王宇倩,周乐,张婴元.Du6859a及其他新的氟喹诺酮类药物的体外抗菌活性[J].中国抗生素杂志,1996,21(3):214-219. 被引量:13
  • 3管正大,医学检验临床意义手册,1994年,335页
  • 4江明性,药理学,1993年,323页
  • 5Vannuffel P, Cocito C. Mechanism of action of streptogramins and macrolides[J]. Drugs, 1996, 51(suppl 1):20-30
  • 6Pechere JC. Streptogramins-a unique class of antibiotics[J]. Drugs 1996, 51(suppl 1): 13-19
  • 7Moellering RC, Linden PK, Reinhardt J, et al. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium[J]. J.Antimicrob Chemother, 1999, 44: 251-261
  • 8Diekema DI, Jones RN. Oxazolidinones: a review[J]. Drugs, 2000, 59: 7-16
  • 9Rubinstein E, Cammarata SK, Oliphant T, et al. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind multicenter study[J]. Clin Inf Dis, 2001, 32: 402-412
  • 10Parenti F, Schito GC, Courvalin P. Teicoplanin: Chemistry and microbiology[J]. J Chemoth, 2000, 12(suppl 5): 5-14

共引文献188

同被引文献147

引证文献29

二级引证文献170

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部